biological e vaccine

The Union government had made an advance payment of Rs 1,500 crore in June 2021 for reserving 30 crore doses. Biological E, a Hyderabad-based vaccine manufacturer, on Monday received…

The company said it has reached production levels of 75 million doses per month at present and would make 100 plus million doses per month from February 2022.  Hyderabad-based Biological E…

“The approvals from the DCGI will encourage us to move forward and produce the Covid-19 vaccine to meet the country's vaccination needs. These approvals will help support subsequent filings…

Biological E's vaccine – a RBD protein sub-unit vaccine – is currently undergoing Phase-3 clinical trials after showing promising results in phases 1 and 2.The government will make an…

The same technology is used by pharma companies to develop and manufacture vaccines against hepatitis B. (Representative image)Amidst the Coronavirus vaccine shortage, the central government…